cyclosporine has been researched along with Hyperplasia in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.90) | 18.7374 |
1990's | 28 (40.58) | 18.2507 |
2000's | 24 (34.78) | 29.6817 |
2010's | 10 (14.49) | 24.3611 |
2020's | 5 (7.25) | 2.80 |
Authors | Studies |
---|---|
Harth, A; Jörres, A; Özcan, F; Tillmann, FP | 1 |
Cao, J; Chen, W; Cheng, H; Qi, N; Wang, X; Xu, KL; Zhang, XT; Zhang, YN; Zhu, JJ | 1 |
Bán, Á; Kun, J; Pintér, E; Schönfeld, B; Szabadi, A | 1 |
Beckmann, KM; Hetzel, U; Martini, F; Rostaher, A | 1 |
Li, HY; Zhang, X; Zhong, H; Zhong, Z; Zhou, T | 1 |
Ballardin, BS; Bonfim, CMS; Carvalho Torres-Pereira, C; Coracin, FL; Mobile, RZ; Ribeiro, LL; Schussel, JL | 1 |
Grillo, E; Jaén-Olasolo, P; Pérez-Gala, S; Vano-Galván, S | 1 |
Cardinale, I; Czarnowicki, T; de Guzman Strong, C; Dhingra, N; Finney, R; Gilleaudeau, P; Gonzalez, J; Guttman-Yassky, E; Khattri, S; Krueger, JG; Rozenblit, M; Shemer, A; Suárez-Fariñas, M; Sullivan-Whalen, M; Xu, H; Zheng, X | 1 |
Donovan, D; Evancho-Chapman, MM; Kanjickal, D; Lopina, S; Schmidt, S | 1 |
Akyazi, H; Alpay, K; Bahadir, S; Cobanoğlu, U; Yayli, S | 1 |
Jang, JI; Kim, HJ; Kim, JH; Kim, JW; Lee, SY; Lim, CY; Park, C; Park, HM; Yoo, JH | 1 |
Chong, AH; Goh, MS; McDonald, SK | 1 |
Bennett, MR; Biessen, EA; Bot, I; Bot, M; Overkleeft, H; Sliedregt, K; van Berkel, TJ; van der Marel, GA; van Heiningen, SH; Xu, X; Yu, H | 1 |
Ahrens, ET; Kadayakkara, DK; Ranganathan, S; Young, WB | 1 |
Asai, N; Hasegawa, Y; Hashimoto, I; Imaizumi, K; Matsuno, T; Tanaka, I; Yokoi, T | 1 |
Bicknell, GR; Murphy, GJ; Nicholson, ML; Toomey, D; Waller, JR | 1 |
Arruda, JA; Barbosa, AH; Brito, FS; Costa, MA; Lima, VC; Pestana, JO; Ribeiro, EP; Tedesco, H | 1 |
Mayor, M; Pérez-España, L; Prats, I; Sanz, A | 1 |
Assaf, C; Boschnakow, A; May, T; Tebbe, B; Zouboulis, ChC | 1 |
Bicknell, GR; Brook, NR; Nicholson, ML; Waller, JR | 1 |
Hakamata, Y; Inoue, S; Kaneko, T; Kobayashi, E; Morishita, Y; Shimizu, H; Tahara, K; Takahashi, M; Takeda, S; Takeyoshi, I | 1 |
Dannenberg, O; Haverich, A; Heublein, B; Oppelt, P; Pethig, K; Wahlers, T | 1 |
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
Donovan, D; Evancho-Chapman, MM; Kanjickal, D; Lopina, S; Schmidt, S; Springhetti, S | 1 |
Trompeter, RS; Willetts, IE | 1 |
Fujishiro, J; Hakamata, Y; Inoue, S; Kaneko, T; Kobayashi, E; Morishita, Y; Murakami, T; Shimizu, H; Takahashi, M; Takeda, S; Takeyoshi, I | 1 |
Cribier, B; Ellero, B; Engel, F; Woehl-Jaegle, ML | 1 |
Chau, YP; Pang, SM | 1 |
Barten, MJ; Bittner, HB; Bold, A; Dhein, S; Garbade, J; Gummert, JF; Mohr, FW; Rahmel, A | 1 |
Fujishiro, J; Hakamata, Y; Hashizume, K; Kobayashi, E; Kudou, S; Murakami, T; Suzuki, C; Takahashi, M; Yasue, T | 1 |
Affleck, A; Chua, S; Kulkarni, K | 1 |
Geraghty, J; Hullett, DA; Kennedy, E; Sollinger, HW; Steele, DM; Stoltenberg, RL | 1 |
Bellón, JM; Buján, MJ; Contreras, L; Dominguez, B; Ga-Honduvilla, N; Hernando, A; Jurado, F | 1 |
Higgins, EM; Hughes, JR; Pembroke, AC; Snowden, S | 1 |
Geraghty, J; Hullett, DA; Kennedy, E; Sollinger, HW; Steele, DM; Stoltenberg, R | 1 |
Bauer, AJ; Halfter, WM; Heeckt, PF; Lee, KK; Schraut, WH | 1 |
Emmerson, RW; Wakelin, SH | 1 |
Belazi, M; Markopoulos, AK; Papanayotou, P; Thomopoulos, GN | 1 |
Beckingham, IJ; Blamey, RW; Dennis, MJ | 1 |
Anderle, SK; Dieter Geratz, J; Pryzwansky, KB; Schwab, JH; Tidwell, RR | 1 |
Evancho, MM; Hirko, MK; McShannic, JR; Schmidt, SP; Sharp, WV; Siebert, JD; Sims, RL | 1 |
Caro, WA; Malkinson, FD; Pakula, A; Valicenti, JM | 1 |
Chuhjo, T; Matsuda, T; Nakao, S; Shiobara, S; Takamatsu, H; Takami, A; Ueda, M; Yamaguchi, M | 1 |
Hullett, DA; Little, DM; Sollinger, HW; Stoltenberg, RL | 1 |
Bang, BK; Kim, YS; Lee, SH; Yang, CW | 1 |
Bellón, JM; Buján, J; Dominguez, B; Hernando, A; Honduvilla, NG; Jurado, F | 1 |
Korn, A; Offermann, G | 1 |
Foegh, ML; Katz, N; Kodama, T; Lou, H; Ramwell, P; Wang, YN | 1 |
Collins, TJ; Karsan, AK; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
Billiar, TR; Kawaharada, N; Kovesdi, I; Lizonova, A; Pham, SM; Shears, LL; Tzeng, E; Watkins, SC | 1 |
Hohenleutner, U; Landthaler, M; Walther, T | 1 |
Ayanoglou, CM; Lesty, C | 1 |
Frazer, IH; Hilditch-Maguire, PA; Lambert, PF; Lieppe, DM; West, D | 1 |
Harden, PN; Harikrishnan, P | 1 |
Bartlett, ST; Blahut, S; Cangro, CB; Drachenberg, CB; Fink, JC; Klassen, DK; Papadimitriou, JC; Weir, MR; Wiland, A | 1 |
Baker, CJ; Barr, ML; McLaughlin, SN; Rose, EA; Schenkel, FA; Starnes, VA; Stouch, BC | 1 |
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J | 1 |
Enosawa, S; Lu, H; Ohmi, K; Suzuki, S | 1 |
Lynch, P; Magariños, G; Marini, M; Remorino, L; Saponaro, A | 1 |
Matsuzawa, A; Nagase, H; Nakano, H; Sakamoto, S; Yasuda, T; Yoshimoto, T | 1 |
Atilla, G; Buduneli, N; Duman, S; Holmstrup, P; Sağol, O | 1 |
Banerjee, AK; Eardley, KS; Radojkovic, M; Taylor, JL; Thomas, ME; Wan, DI | 1 |
Gera, I; Keglevich, T; Windisch, P | 1 |
Bacher, J; Das, SR; Parlow, AF; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
Barber, AE; Fahey, TJ; Jones, WG; Kapur, S; Minei, JP; Shires, GT | 1 |
Garside, P; Grencis, RK; Mowat, AM | 1 |
Garden, J; Pakula, A | 1 |
Atlef, N; Doll, N; Hermitte, L; Payan, MJ; Scheimann, A; Vague, P; Vialettes, B | 1 |
Duell, EA; Elder, JT; Esmann, J; Fisher, GJ; Gupta, AK; Nickoloff, BJ; Talwar, HS; Voorhees, JJ | 1 |
3 review(s) available for cyclosporine and Hyperplasia
Article | Year |
---|---|
The efficacy and safety of cyclosporine A plus androgen versus androgen alone for adult patients with non-severe aplastic anemia in China: a meta-analysis of randomized controlled trials.
Topics: Adult; Androgens; Anemia, Aplastic; Cyclosporine; Hirsutism; Humans; Hyperplasia; Randomized Controlled Trials as Topic | 2022 |
Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Topics: Cholesterol; Creatinine; Cyclophosphamide; Cyclosporine; Drug Resistance; Gingiva; Humans; Hyperplasia; Hypertension; Immunosuppressive Agents; Infections; Nephrotic Syndrome; Proteinuria; Steroids; Tacrolimus | 2019 |
Experience with cyclosporine in pediatric renal transplantation.
Topics: Age Factors; Child; Cyclosporine; Humans; Hyperplasia; Hypertension; Immunosuppressive Agents; Kidney Transplantation | 2004 |
5 trial(s) available for cyclosporine and Hyperplasia
Article | Year |
---|---|
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients.
Topics: Azathioprine; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclosporine; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Hyperplasia; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Stents; Tunica Intima | 2003 |
Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C-Reactive Protein; Cyclosporine; Female; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Inflammation; Male; Mycophenolic Acid; Pilot Projects; Prednisolone; Prospective Studies; Ultrasonography | 2004 |
Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
Topics: Administration, Oral; Creatinine; Cyclosporine; Double-Blind Method; Emulsions; Gingiva; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Time Factors; Urea | 1996 |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
Topics: Adult; Biopsy; Cyclosporine; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperplasia; Immunosuppressive Agents; Islets of Langerhans; Male; Microscopy, Electron; Middle Aged; Pancreas Transplantation; Tacrolimus; Time Factors; Transplantation, Homologous; Vacuoles | 1999 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; HLA Antigens; Humans; Hyperplasia; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Photopheresis; Pilot Projects; Prednisone; Prospective Studies; Safety; Tunica Intima | 2000 |
61 other study(ies) available for cyclosporine and Hyperplasia
Article | Year |
---|---|
Cyclosporine A-Induced Conchal Hyperplasia with Nasal Obstruction in a Patient with Membranous Nephropathy.
Topics: Aged; Cyclosporine; Female; Gingival Hyperplasia; Glomerulonephritis, Membranous; Hirsutism; Humans; Hyperplasia; Immunosuppressive Agents; Nasal Obstruction; Proteinuria; Turbinates | 2022 |
Can gingival hyperplasia caused by cyclosporin A be prevented by removing dental plaque?
Topics: Cyclosporine; Gingival Hyperplasia; Humans; Hyperplasia; Kidney Transplantation; Prevalence | 2022 |
Cyclosporine induced generalized hyperkeratosis in a dog.
Topics: Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Hyperplasia; Immunosuppressive Agents; Papilloma | 2023 |
A case series of medication-related fibrovascular hyperplasia following hematopoietic stem cell transplantation for Fanconi anemia.
Topics: Amlodipine; Calcium Channel Blockers; Child; Cyclosporine; Fanconi Anemia; Female; Granuloma, Pyogenic; Hematopoietic Stem Cell Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Male; Mouth Diseases; Phenobarbital | 2021 |
[Multiple sebaceous hyperplasia secondary to ciclosporin in a heart transplant patient].
Topics: Cyclosporine; Facial Dermatoses; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Sebaceous Glands | 2013 |
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
Topics: Adolescent; Adult; Aged; Biomarkers; Cluster Analysis; Cyclosporine; Dendritic Cells; Dermatitis, Atopic; Epidermis; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Hyperplasia; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Phenotype; Signal Transduction; T-Lymphocyte Subsets; Treatment Outcome; Young Adult | 2014 |
Sustained local drug delivery from a novel polymeric ring to inhibit intimal hyperplasia.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Blood Vessels; Compressive Strength; Cyclosporine; Dogs; Drug Delivery Systems; Humans; Hyperplasia; Immunosuppressive Agents; Lactic Acid; Materials Testing; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Swine; Tunica Intima | 2010 |
Coexistence of basal cell carcinomas and multiple sebaceous gland hyperplasias in a cyclosporine (ciclosporin)-treated renal transplant recipient.
Topics: Carcinoma, Basal Cell; Cyclosporine; Face; Humans; Hyperplasia; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nose; Sebaceous Gland Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.
Topics: Adenoma; Anal Gland Neoplasms; Animals; Cyclosporine; Dog Diseases; Dogs; Hyperplasia; Immunosuppressive Agents; Male; Prostate; Prostatic Diseases; Treatment Outcome | 2010 |
Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients.
Topics: Adult; Cyclosporine; Dermatologic Agents; Facial Dermatoses; Humans; Hyperplasia; Immunosuppressive Agents; Isotretinoin; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands | 2011 |
Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Topics: Amino Acid Motifs; Animals; Apolipoproteins E; Calcineurin; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Proliferation; Chlorocebus aethiops; COS Cells; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Hyperplasia; Immunosuppressive Agents; Jurkat Cells; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; NFATC Transcription Factors; Peptides; Peritonitis; Recurrence; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes; Transfection | 2012 |
Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI.
Topics: Animals; Anti-Inflammatory Agents; Colon; Cyclosporine; Dexamethasone; Female; Fluorine; Fluorocarbons; Hyperplasia; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Macrophages; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Real-Time Polymerase Chain Reaction | 2012 |
Interstitial pneumonia and nodular regenerative hyperplasia of the liver as initial manifestations of polyarteritis nodosa.
Topics: Aged; Cyclosporine; Disease Progression; Dyspnea; Fatal Outcome; Humans; Hyperplasia; Hypertension, Portal; Immunosuppressive Agents; Liver Failure; Liver Regeneration; Lung Diseases, Interstitial; Male; Polyarteritis Nodosa; Prednisolone; Tomography, X-Ray Computed | 2012 |
Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia.
Topics: Animals; Calcineurin Inhibitors; Carotid Artery, Common; Cell Division; Cyclosporine; Drug Therapy, Combination; Hyperplasia; Immunosuppressive Agents; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sirolimus; Tacrolimus; Tissue Inhibitor of Metalloproteinase-1; Tunica Intima | 2002 |
[High prevalence of sebaceous hyperplasias in renal transplants].
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Facial Dermatoses; Female; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Sebaceous Gland Diseases; Sebaceous Glands; Spain | 2003 |
Ciclosporin A-induced sebaceous gland hyperplasia.
Topics: Adult; Aged; Cyclosporine; Drug Eruptions; Humans; Hyperplasia; Immunosuppressive Agents; Male; Sebaceous Glands | 2003 |
Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia.
Topics: Angioplasty, Balloon; Animals; Carotid Artery, Common; Collagen Type III; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Hyperplasia; Immunosuppressive Agents; Male; Matrix Metalloproteinase Inhibitors; Rats; Rats, Sprague-Dawley; Sirolimus; Tacrolimus; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta; Tunica Intima | 2004 |
Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models.
Topics: Animals; Aorta; Arteriosclerosis; Cyclosporine; Hyperplasia; Immunosuppressive Agents; Male; Models, Animal; Rats; Rats, Inbred Lew; Ribonucleosides; Transplantation Immunology; Tunica Intima | 2003 |
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis | 2004 |
Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia.
Topics: Animals; Cyclosporine; Dogs; Drug Delivery Systems; Drug Implants; Femoral Vein; Hydrogels; Hyperplasia; Jugular Veins; Kinetics; Polyethylene Glycols; Sterilization; Tunica Intima | 2004 |
Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
Topics: Animals; Aorta, Abdominal; Apoptosis; Arteriosclerosis; Cyclosporine; Hyperplasia; Immunosuppressive Agents; Kidney; Macrophages; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous; Tunica Intima; Weight Loss | 2004 |
[Diffuse sebaceous hyperplasia of the face induced by cyclosporine].
Topics: Adult; Cyclosporine; Drug Eruptions; Facial Dermatoses; Humans; Hyperplasia; Immunosuppressive Agents; Male; Sebaceous Glands | 2005 |
Cyclosporin-induced sebaceous hyperplasia in renal transplant patients.
Topics: Adult; Cyclosporine; Face; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands; Skin Diseases, Papulosquamous | 2005 |
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
Topics: Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Gingival Diseases; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Lung Transplantation; Metabolic Clearance Rate; Mycophenolic Acid; Tacrolimus | 2005 |
Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
Topics: Animals; Aorta; Aortic Diseases; Arterial Occlusive Diseases; Blood Cell Count; Cyclosporine; Drug Therapy, Combination; Hyperplasia; Immunohistochemistry; Immunosuppressive Agents; Kidney Diseases; Macrophages; Male; Mycophenolic Acid; Rats; Rats, Inbred Strains; Receptors, Lysosphingolipid; Retreatment; Sulfhydryl Compounds; T-Lymphocytes; Transplantation, Homologous; Tunica Intima | 2006 |
Florid hyperplastic folliculitis on the chin in a male renal transplant patient.
Topics: Chin; Cyclosporine; Facial Dermatoses; Folliculitis; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 2008 |
Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
Topics: Animals; Aorta; Cyclosporine; Graft Rejection; Graft Survival; Hyperplasia; Immunosuppressive Agents; Male; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima; Tunica Media | 1995 |
Atherogenic effects of cyclosporine in an experimental model of arterial autograft.
Topics: Animals; Arteries; Arteriosclerosis; Cyclosporine; Female; Hyperplasia; Immunosuppressive Agents; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Transplantation, Autologous | 1995 |
Cyclosporin-induced periungual granulation tissue.
Topics: Adult; Cyclosporine; Granulation Tissue; Humans; Hyperplasia; Male; Nail Diseases | 1995 |
Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
Topics: Animals; Aorta, Abdominal; Cyclosporine; Graft Rejection; Hyperplasia; Muscle, Smooth, Vascular; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Prolonged in vivo administration of cyclosporine causes enteric smooth muscle hyperplasia in normal rat intestine and small bowel grafts.
Topics: Animals; Carbachol; Cell Division; Cyclosporine; Hyperplasia; Intestine, Small; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Excess granulation tissue development during treatment with cyclosporin.
Topics: Adolescent; Cyclosporine; Granulation Tissue; Humans; Hyperplasia; Male; Psoriasis | 1994 |
Cyclosporin-induced gingival hyperplasia: an ultrastructural study of the oral epithelial prickle cells.
Topics: Actin Cytoskeleton; Adult; Cell Nucleus; Cyclosporine; Desmosomes; Epithelium; Female; Gingiva; Humans; Hyperplasia; Kidney Transplantation; Male; Microscopy, Electron; Middle Aged | 1993 |
Evaluation of animal models of chronic vascular rejection.
Topics: Animals; Arteriosclerosis; Atrophy; Chronic Disease; Cyclosporine; Disease Models, Animal; Fibrosis; Graft Rejection; Hyperplasia; Ischemia; Kidney Transplantation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Renal Circulation | 1993 |
Suppression of local and systemic responses in streptococcal cell wall-induced acute inflammation of the air pouch by cyclosporine A. Comparison with the effects of two anti-inflammatory bis-benzimidazoles.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Bone Marrow; Cell Wall; Cyclosporine; Female; Hematopoietic System; Hemoglobins; Hyperplasia; Inflammation; Injections, Subcutaneous; Leukocytes; Macrophages; Rats; Rats, Inbred Lew; Spleen; Streptococcus pyogenes | 1993 |
Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Cilazapril; Cyclosporine; Dogs; Female; Femoral Artery; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Male; Time Factors; Tunica Intima; Vascular Patency | 1993 |
Papilloma development in cyclosporine-treated patients.
Topics: Adult; Cyclosporine; Humans; Hyperplasia; Male; Papilloma; Skin; Skin Neoplasms | 1993 |
Relative erythroid hyperplasia in the bone marrow at diagnosis of aplastic anaemia: a predictive marker for a favourable response to cyclosporine therapy.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Bone Marrow; Cyclosporine; Erythroblasts; Female; Humans; Hyperplasia; Male; Middle Aged; Multivariate Analysis; Patient Selection; Retrospective Studies; Treatment Outcome | 1996 |
Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
Topics: Administration, Oral; Animals; Aorta; Chronic Disease; Cyclosporine; Graft Rejection; Hyperplasia; Immunosuppressive Agents; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima | 1996 |
Expression of proliferating cell nuclear antigen-positive cells during compensatory renal growth in cyclosporine-treated rats.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Biomarkers; Cell Division; Cyclosporine; Hyperplasia; Immunohistochemistry; Kidney; Male; Nephrectomy; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
Cyclosporin A delays the presentation of intimal hyperplasia in an experimental model of arterial autograft.
Topics: Animals; Arteries; Autoradiography; Cyclosporine; Female; Hyperplasia; Immunosuppressive Agents; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Transplantation, Autologous | 1996 |
L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
Topics: Animals; Antineoplastic Agents; Aorta; Arginine; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Hyperplasia; Immunosuppressive Agents; Insulin-Like Growth Factor I; Interleukin-6; Macrophages; Male; Nitric Oxide; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous | 1996 |
Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
Topics: Aorta; Aortic Diseases; Cholesterol; Cohort Studies; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Follow-Up Studies; Forecasting; Heart Transplantation; Humans; Hypercholesterolemia; Hyperplasia; Hypertriglyceridemia; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Transplantation Immunology; Transplantation, Homologous; Triglycerides; Tunica Intima; Ultrasonography, Interventional | 1997 |
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Cyclosporine; Genetic Therapy; Graft Rejection; Histocompatibility Antigens; Hyperplasia; Immunosuppressive Agents; Nitric Oxide; Nitric Oxide Synthase; Organ Transplantation; Rats; Rats, Wistar; Transplantation, Homologous; Tunica Intima | 1997 |
[Sebaceous gland hyperplasia as a side effect of cyclosporin A. Treatment with the CO2 laser].
Topics: Biopsy; Cyclosporine; Ear, External; Face; Forehead; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Laser Therapy; Male; Middle Aged; Sebaceous Gland Diseases; Sebaceous Glands | 1998 |
Cyclosporin A-induced gingival overgrowth in the rat: a histological, ultrastructural and histomorphometric evaluation.
Topics: Anatomy, Cross-Sectional; Animals; Cell Count; Collagen; Connective Tissue; Cyclosporine; Epithelial Attachment; Epithelium; Extracellular Matrix; Fibroblasts; Follow-Up Studies; Gingiva; Gingival Overgrowth; Hyalin; Hyperplasia; Immunosuppressive Agents; Keratins; Male; Microscopy, Electron; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Vasodilation | 1999 |
T cell-mediated and non-specific inflammatory mechanisms contribute to the skin pathology of HPV 16 E6E7 transgenic mice.
Topics: Age Factors; Animals; Cyclosporine; Dinitrochlorobenzene; Female; Humans; Hyperplasia; Immunity, Cellular; Immunosuppressive Agents; Irritants; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Mice, Transgenic; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Repressor Proteins; Skin; Skin Diseases; Specific Pathogen-Free Organisms; T-Lymphocytes | 1999 |
Tacrolimus can resolve cyclosporin-induced gingival hyperplasia.
Topics: Adult; Cyclosporine; Gingiva; Humans; Hyperplasia; Immunosuppressive Agents; Male; Tacrolimus | 1999 |
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 1999 |
The proliferative response of p53 knock-out mouse-derived vascular smooth muscle cell line, P53LMAC01, to PDGF, when compared with human aortic smooth muscle cells.
Topics: Animals; Aorta; Arteriosclerosis; Cell Division; Cell Line; Culture Media, Serum-Free; Cyclosporine; DNA Replication; Genes, p53; Graft Rejection; Heart Transplantation; Humans; Hyperplasia; Mice; Mice, Knockout; Models, Animal; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Species Specificity; Tumor Suppressor Protein p53 | 2001 |
Eruptive lesions in a patient with bone marrow transplantation.
Topics: Adult; Biopsy; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Reaction; Humans; Hyperplasia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Sebaceous Glands | 2001 |
Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.
Topics: Animals; Antigens, Viral; CD4-Positive T-Lymphocytes; Cell Movement; Cyclosporine; Female; Histocompatibility Antigens Class II; Hyperplasia; Immunosuppressive Agents; Lymph Nodes; Male; Mammary Tumor Virus, Mouse; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Antigen, T-Cell, alpha-beta; Retroviridae Infections; Superantigens | 2001 |
Immunohistochemical analysis of epidermal growth factor receptor in cyclosporin A-induced gingival overgrowth.
Topics: Adolescent; Adult; Case-Control Studies; Cyclosporine; ErbB Receptors; Female; Gingiva; Gingival Overgrowth; Humans; Hyperplasia; Immunohistochemistry; Immunosuppressive Agents; Keratinocytes; Kidney Transplantation; Male; Periodontal Index; Statistics, Nonparametric | 2001 |
Transplant-associated inflammatory breast disease.
Topics: Adult; Cell Division; Cyclosporine; Female; Fibroblasts; Humans; Hypercalcemia; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Mastitis | 2002 |
[Treatment of periodontitis associated with cyclosporin-induced severe gingival hyperplasia with regular mechanical plaque removal in a patient with renal transplantation (Case report)].
Topics: Cyclosporine; Dental Plaque; Female; Gingiva; Gingivitis; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Periodontitis; Severity of Illness Index; Treatment Outcome | 2002 |
Cyclosporine A-induced mammary hyperplasia and hyperprolactinemia in New Zealand White rabbits.
Topics: Animals; Cyclosporine; Disease Models, Animal; Estradiol; Female; Humans; Hyperplasia; Hyperprolactinemia; Immunosuppressive Agents; Mammary Glands, Animal; Methylprednisolone; Progesterone; Prolactin; Rabbits | 2001 |
Effect of cyclosporine on adrenocortical response to injury and infection.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Burns; Corticosterone; Cyclosporine; DNA; Hyperplasia; Male; Organ Size; Proteins; Pseudomonas Infections; Rats; Rats, Wistar; RNA; Wound Infection | 1992 |
T lymphocyte dependent enteropathy in murine Trichinella spiralis infection.
Topics: Animals; Cyclosporine; Enteritis; Hyperplasia; Intestinal Diseases, Parasitic; Intestinal Mucosa; Leukocyte Count; Male; Mice; Parasite Egg Count; T-Lymphocytes; Trichinellosis | 1992 |
Sebaceous hyperplasia and basal cell carcinoma in a renal transplant patient receiving cyclosporine.
Topics: Carcinoma, Basal Cell; Cyclosporine; Humans; Hyperplasia; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands; Skin Neoplasms | 1992 |
High dose nicotinamide fails to prevent diabetes in BB rats.
Topics: Age Factors; Animals; Autoimmune Diseases; Blood Glucose; Cyclosporine; Deferoxamine; Diabetes Mellitus, Experimental; DNA Damage; Drug Evaluation, Preclinical; Hyperplasia; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; NAD; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred BB | 1989 |
Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.
Topics: Administration, Topical; Animals; Arachidonic Acid; Arachidonic Acids; Cyclosporine; Cyclosporins; Dermatitis; Dinoprostone; Enzyme Activation; Epidermis; Hyperplasia; Interleukins; Mice; Mice, Hairless; Ornithine Decarboxylase; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Transglutaminases | 1989 |